Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Pharmaceutical companies were dealt back-to-back blows over the last 24 hours in their fight against the Biden-era Medicare Drug Price Negotiation Program, which the Trump Administration has ...

Pharma Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds' By Fraiser Kansteiner Aug 7, 2025 11:04am Eli Lilly David Ricks pharma CEO Earnings ...

Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug The smaller market now envisioned for vepdegestrant has changed both companies’ stance on a deal that granted each an equal share of the ...

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Enrollment and Re-Certification of Entities in the 340B Drug Pricing ...

Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue.

Motor carriers with an ELP violation on the record might be more dangerous -- and certainly are more crash-prone -- than those with speeding or even drug-and-alcohol violations.

The 340B Drug Pricing Program was created to improve access to care at safety-net hospitals and clinics, but critics argue that the program hasn’t met this goal.